Items where Funder is Cancer Research UK Supplier No: 138573.

The University of Leeds

Castaneda-Garcia, C, Iyer, V, Nsengimana, J et al. (11 more authors) (2022) Defining novel causal SNPs and linked phenotypes at melanoma-associated loci. Human Molecular Genetics, 31 (17). pp. 2845-2856. ISSN 0964-6906

McNamara, MG, Swain, J, Craig, Z et al. (21 more authors) (2023) NET-02: a randomised, non-comparative, phase II trial of nal-IRI/5-FU or docetaxel as second-line therapy in patients with progressive poorly differentiated extra-pulmonary neuroendocrine carcinoma. eClinicalMedicine, 60. 102015. ISSN 2589-5370

Brownlie, RJ, Kennedy, R, Wilson, EB et al. (18 more authors) (2023) Cytokine receptor IL27RA is an NF-kB-responsive gene involved in CD38 upregulation in multiple myeloma. Blood Advances, 7 (15). pp. 3874-3890. ISSN 2473-9529

Bhaskaran, D., Savage, J., Patel, A. et al. (9 more authors) (2024) A randomised phase II trial of temozolomide with or without cannabinoids in patients with recurrent glioblastoma (ARISTOCRAT): protocol for a multi-centre, double-blind, placebo-controlled trial. BMC Cancer, 24 (1). 83. ISSN 1471-2407

Pawlyn, C., Menzies, T. orcid.org/0000-0003-3896-7228, Davies, F.E. et al. (12 more authors) (2020) The Addition of Carfilzomib to a Lenalidomide-Based Triplet Improves Outcomes in Newly Diagnosed Transplant Eligible Myeloma Patients with Renal Impairment: A Subgroup Analysis of the Myeloma XI Trial. In: Blood. 62nd ASH Annual Meeting and Exposition, 05-08 Dec 2020, Virtual. American Society of Hematology , pp. 40-43.

Agbuduwe, C, Iqbal, G, Cairns, DA orcid.org/0000-0002-2338-0179 et al. (12 more authors) (2022) Clinical Characteristics and Outcomes of IgD Myeloma: Experience across UK National Trials. Blood Advances, 6 (17). pp. 5113-5123. ISSN 2473-9529

Hillmen, P, Pitchford, A, Bloor, A et al. (29 more authors) (2023) Ibrutinib and rituximab versus fludarabine, cyclophosphamide, and rituximab for patients with previously untreated chronic lymphocytic leukaemia (FLAIR): interim analysis of a multicentre, open-label, randomised, phase 3 trial. The Lancet Oncology, 24 (5). pp. 535-552. ISSN 1470-2045

Hillmen, P., Pitchford, A., Bloor, A. et al. (29 more authors) (2023) Ibrutinib and rituximab versus fludarabine, cyclophosphamide, and rituximab for patients with previously untreated chronic lymphocytic leukaemia (FLAIR): interim analysis of a multicentre, open-label, randomised, phase 3 trial. Lancet Oncology, 24 (5). pp. 535-552. ISSN 1470-2045

Platt, JR, Williams, CJM orcid.org/0000-0002-1574-653X, Craig, Z et al. (4 more authors) (2023) Personalising Neoadjuvant Chemotherapy for Locally Advanced Colon Cancer: Protocols for the International Phase III FOxTROT2 and FOxTROT3 Randomised-Controlled Trials. Colorectal Disease, 25 (3). pp. 357-366. ISSN 1462-8910

Alzahrani, N.M., Henry, A.M. orcid.org/0000-0002-5379-6618, Clark, A.K. et al. (3 more authors) (2024) Dosimetric impact of contour editing on CT and MRI deep‐learning autosegmentation for brain OARs. Journal of Applied Clinical Medical Physics, 25 (5). e14345. ISSN 1526-9914

Andratschke, N., Willmann, J., Appelt, A.L. orcid.org/0000-0003-2792-9218 et al. (16 more authors) (2022) European Society for Radio-therapy and Oncology and European Organisation for Research and Treatment of Cancer consensus on re-irradiation: definition, reporting, and clinical decision making. The Lancet Oncology, 23 (10). e469-e478. ISSN 1470-2045

Andratschke, N, Willmann, J, Appelt, AL orcid.org/0000-0003-2792-9218 et al. (16 more authors) (2022) European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus on re-irradiation: definition, reporting, and clinical decision making. The Lancet Oncology, 23 (10). e469-e478. ISSN 1470-2045

Lorenzo Polo, A., Nix, M. orcid.org/0000-0001-7228-7344, Thompson, C. et al. (6 more authors) (2024) Improving hybrid image and structure-based deformable image registration for large internal deformations. Physics in Medicine & Biology, 69 (9). 095011. ISSN 0031-9155

Fatania, K orcid.org/0000-0003-2421-1083, Mohamud, F, Clark, A et al. (5 more authors) (2022) Intensity standardization of MRI prior to radiomic feature extraction for artificial intelligence research in glioma-a systematic review. European Radiology, 32 (10). pp. 7014-7025. ISSN 0938-7994

Portner, R., McWilliam, A., Zhong, J. et al. (16 more authors) (2022) Prostate Magnetic Resonance Imaging Delta-Radiomics during Image-Guided Conventional Fractionation and Stereotactic Ablative Radiotherapy. In: UNSPECIFIED.

Murray, LJ orcid.org/0000-0003-0658-6455, Appelt, AL, Ajithkumar, T et al. (9 more authors) (2023) Re-irradiation: From Cell Lines to Patients, Filling the (Science) Gap in the Market. Clinical Oncology, 35 (5). pp. 318-322. ISSN 0936-6555

Russell, E., O’Hara, C., Andersson, S. et al. (4 more authors) (2024) An automated assessment pipeline to identify prostate treatments that need adaptive radiotherapy. Journal of Radiotherapy in Practice, 23. e29. ISSN 1460-3969

Lincoln, A, Benton, S, Piggott, C et al. (6 more authors) (2022) Exploring the utility and acceptability of Faecal immunochemical testing (FIT) as a novel intervention for the improvement of colorectal Cancer (CRC) surveillance in individuals with lynch syndrome (FIT for lynch study): a single-arm, prospective, multi-centre, non-randomised study. BMC Cancer, 22 (1). 1144. ISSN 1471-2407

Rosendahl Huber, A., Pleguezuelos-Manzano, C., Puschhof, J. et al. (14 more authors) (2024) Improved detection of colibactin-induced mutations by genotoxic E. coli in organoids and colorectal cancer. Cancer Cell, 42 (3). 487-496.e6. ISSN 1535-6108

Birch, RJ orcid.org/0000-0003-1579-1397, Downing, A orcid.org/0000-0002-0335-7801, Finan, PJ et al. (3 more authors) (2021) Improving outcome prediction in individuals with colorectal cancer and diabetes by accurate assessment of vascular complications: Implications for clinical practice. European Journal of Surgical Oncology, 47 (5). pp. 999-1004. ISSN 0748-7983

Horne, A., Ali, A., Brown, S. et al. (28 more authors) (2022) 153 CONCORDE: a phase Ib platform study of novel agents in combination with conventional radiotherapy in non-small cell lung cancer (NSCLC). In: 20th Annual British Thoracic Oncology Group Conference 2022, 27-28 Jan 2022, Virtual.

Horne, A., Brown, S., Butterworth, K. et al. (26 more authors) (2022) EP05.01-007 CONCORDE - A Phase Ib Platform Study of Novel Agents in COmbinatioN with COnventional RaDiothErapy in Non-small Cell Lung Cancer (NSCLC). Journal of Thoracic Oncology, 17 (9). s267-s268. ISSN 1556-0864

King, S.W., Chapman, L.S., Smith, T.J. et al. (2 more authors) (2025) Wearable Sensors to Aid Rehabilitation Following Total Knee Arthroplasty: Experiences of Trial Participants. Cureus, 17 (3). e80752. ISSN 2168-8184

Salmond, R orcid.org/0000-0002-1807-1056 (2023) Regulation of T cell activation and metabolism by Transforming Growth Factor-Beta. Biology, 12 (2). 297. ISSN 2079-7737

Winters, C., Norton, J., Valdastri, P. orcid.org/0000-0002-2280-5438 et al. (1 more author) (2023) P233 Barriers and facilitators to colonoscopy in patients and endoscopists. In: BSG LIVE’23, 19-22 Jun 2023, Liverpool.

Winters, C., Norton, J., Valdastri, P. orcid.org/0000-0002-2280-5438 et al. (1 more author) (2023) P234 Patient and endoscopist perceptions of new technologies in colonoscopy. In: BSG LIVE’23, 19-22 Jun 2023, Liverpool.

Winters, C orcid.org/0000-0001-5773-2876, Subramanian, V orcid.org/0000-0003-3603-0861 and Valdastri, P orcid.org/0000-0002-2280-5438 (2022) Robotic, self-propelled, self-steerable, and disposable colonoscopes: Reality or pipe dream? A state of the art review. World Journal of Gastroenterology, 28 (35). pp. 5093-5110. ISSN 1007-9327

Norton, J.C. orcid.org/0000-0001-9981-5936, Martin, J.W., Winters, C. et al. (4 more authors) (2024) The adult large bowel: describing environment morphology for effective biomedical device development. Progress in Biomedical Engineering, 6 (3). 032003. ISSN 2516-1091

Shiu, K-K, Seligmann, JF orcid.org/0000-0003-4379-6005, Graham, J et al. (15 more authors) (2022) NEOPRISM-CRC: Neoadjuvant pembrolizumab stratified to tumor mutation burden for high-risk stage 2 or stage 3 deficient-MMR/MSI-high colorectal cancer. In: Journal of Clinical Oncology. 2022 ASCO Annual Meeting I, 03-07 Jun 2022, Chicago, USA. American Society of Clinical Oncology .

Royle, K.-L. orcid.org/0000-0003-0225-1199, Meads, D., Visser-Rogers, J.K. et al. (2 more authors) (2023) How is overall survival assessed in randomised clinical trials in cancer and are subsequent treatment lines considered? A systematic review. Trials, 24. 708. ISSN 1745-6215

Pawlyn, C. orcid.org/0000-0002-7190-0028, Schjesvold, F.H. orcid.org/0000-0003-1096-0569, Cairns, D.A. orcid.org/0000-0002-2338-0179 et al. (13 more authors) (2024) Progression-free survival as a surrogate endpoint in myeloma clinical trials: an evolving paradigm. Blood Cancer Journal, 14. 134.

Rawstron, A., Webster, N., Dalal, S. et al. (15 more authors) (2023) Using Peripheral Blood (PB) Measurable Residual Disease (MRD) Levels to Predict <0.01% Bone Marrow Disease (BM uMRD4): Identification of Effective PB Targets for CLL Treatment Cessation in the Ibrutinib+Venetoclax Arm of the FLAIR Trial. In: Blood. 65th ASH: Annual Meeting & Exposition, 09-12 Dec 2023, San Diego, USA. American Society of Hematology , p. 632.

Gilbert, A. orcid.org/0000-0002-9142-1227, Samuel, R., Cagney, D. et al. (3 more authors) (2024) The use of master protocols for efficient trial design to evaluate radiotherapy interventions: a systematic review. Journal of the National Cancer Institute, 116 (8). pp. 1220-1229. ISSN 0027-8874

Slevin, F orcid.org/0000-0002-7176-904X, Beasley, M, Speight, R et al. (5 more authors) (2021) Evaluation of Clinician Contouring for Pancreatic Stereotactic Ablative Radiotherapy During a Contouring Workshop Organised by the Royal College of Radiologists. Clinical Oncology, 33 (3). e196-e197. ISSN 0936-6555

Slevin, F orcid.org/0000-0002-7176-904X and Henry, AM orcid.org/0000-0002-5379-6618 (2021) Muscle-invasive Bladder Cancer in the Elderly Patient With a Focus on Hypofractionated Radiotherapy. Clinical Oncology, 33 (6). pp. 369-375. ISSN 0936-6555

Brown, S, Beasley, M, Mcnair, H et al. (3 more authors) (2019) A survey of the practice of stereotactic ablative radiotherapy for lung cancer in the UK on behalf of the Advanced Radiotherapy Technologies Network (ART-NET). In: 17th Annual British Thoracic Oncology Group Conference 2019, 23-25 Jan 2019, Dublin, Ireland.

Smith, L orcid.org/0000-0002-4280-6323, Carmichael, J, Cook, G orcid.org/0000-0001-7196-7364 et al. (2 more authors) (2023) Development and Internal Validation of a Risk Prediction Model to Identify Myeloma Based on Routine Blood Tests: A Case-Control Study. Cancers, 15 (3). 975. ISSN 2072-6694

Lloyd, KE orcid.org/0000-0002-0420-2342, Hall, LH, King, N orcid.org/0000-0002-4215-2323 et al. (6 more authors) (2022) Aspirin use for cancer prevention: a systematic review of public, patient and healthcare provider attitudes and adherence behaviours. Preventive Medicine, 154. 106872. ISSN 0091-7435

Lloyd, KE orcid.org/0000-0002-0420-2342, Hall, LH orcid.org/0000-0001-9032-4540, Ziegler, L orcid.org/0000-0001-9563-5014 et al. (5 more authors) (2022) A factorial randomised trial investigating factors influencing general practitioners’ willingness to prescribe aspirin for cancer preventive therapy in Lynch syndrome: a registered report. British Journal of General Practice. BJGP.2021.0610. ISSN 0960-1643

Gil, N, Fisher, A, Beeken, RJ orcid.org/0000-0001-8287-9351 et al. (5 more authors) (2022) The role of partner support for health behaviours in people living with and beyond cancer: A qualitative study. Psycho-oncology, 31 (11). pp. 1997-2006. ISSN 1057-9249

Corry, SM, McCorry, AMB, Lannagan, TRM et al. (31 more authors) (2022) Activation of innate-adaptive immune machinery by poly(I:C) exposes a therapeutic vulnerability to prevent relapse in stroma-rich colon cancer. Gut, 71 (12). pp. 2502-2517. ISSN 0017-5749

Malla, S.B. orcid.org/0000-0001-5862-3815, Byrne, R.M. orcid.org/0000-0001-6505-6345, Lafarge, M.W. et al. (40 more authors) (2024) Pathway level subtyping identifies a slow-cycling biological phenotype associated with poor clinical outcomes in colorectal cancer. Nature Genetics, 56. pp. 458-472. ISSN 1061-4036

Kennedy, F orcid.org/0000-0002-4910-2505, Lally, P, Miller, NE et al. (5 more authors) (2023) Fatigue, quality of life and associations with adherence to the World Cancer Research Fund guidelines for health behaviours in 5835 adults living with and beyond breast, prostate and colorectal cancer in England: A cross-sectional study. Cancer Medicine, 12 (11). pp. 12705-12716. ISSN 2045-7634

Smith, S., Fisher, A., Lally, P. J. et al. (4 more authors) (2024) Perceiving a Need for Dietary Change in Adults Living With and Beyond Cancer: A Cross Sectional Study. Cancer Medicine, 13 (4). e7073. ISSN 2045-7634

Smith, S., Lally, P., Steptoe, A. et al. (3 more authors) (2024) Prevalence of loneliness and associations with health behaviours and body mass index in 5835 people living with and beyond cancer: a cross-sectional study. BMC Public Health, 24 (1). 635.

Birkeälv, S, Harland, M, Matsuyama, LSAS et al. (15 more authors) (2023) Mutually exclusive genetic interactions and gene essentiality shape the genomic landscape of primary melanoma. Journal of Pathology, 259 (1). pp. 56-68. ISSN 0022-3417

Gilbert, A. orcid.org/0000-0002-9142-1227, Webster, J., Brown, S. et al. (8 more authors) (2022) OC-0269 Standard vs dose escalated chemoradiotherapy in anal cancer: Phase II results of the PLATO-ACT5 RCT. Radiotherapy & Oncology, 170 (1). s225-s226. ISSN 0167-8140

Gilbert, A. orcid.org/0000-0002-9142-1227, Webster, J., Brown, S. et al. (9 more authors) (2023) OC-0831 Standard vs dose reduced chemoradiotherapy in anal cancer: short-term results of the PLATO-ACT4 RCT. Radiotherapy & Oncology, 182 (1). s702-s703. ISSN 0167-8140

Short, S. orcid.org/0000-0003-4423-7256, Kendall, J., West, E. orcid.org/0000-0001-7449-120X et al. (7 more authors) (2022) P11.64.A Long-term follow up and translational data from the ReoGlio phase Ib trial of GM-CSF and intravenous pelareorep (Reovirus) alongside standard of care in GBM. In: Neuro-Oncology. 17th Meeting of the European Association of Neuro-Oncology, 15-18 Sep 2022, Vienna, Austria. Oxford University Press , ii73-ii73.

Munir, T., Cairns, D.A. orcid.org/0000-0002-2338-0179, Bloor, A. et al. (29 more authors) (2023) Chronic Lymphocytic Leukemia Therapy Guided by Measurable Residual Disease. New England Journal of Medicine. ISSN 0028-4793

Pearce, J., Martin, S., Heritage, S. et al. (8 more authors) (2025) Frailty and outcomes in adults undergoing systemic anti-cancer treatment: a systematic review and meta-analysis. JNCI: Journal of the National Cancer Institute. djaf017. ISSN 0027-8874

Snowden, JA, Ahmedzai, SH, Cox, A et al. (10 more authors) (2022) Association of genetic variants with patient reported quality of life and pain experience in patients in the UK NCRI Myeloma X Relapse [Intensive]) trial; an exploratory study. Bone Marrow Transplantation, 57 (10). pp. 1507-1513. ISSN 0268-3369

Baxter, M.A. orcid.org/0000-0002-5773-8650, Spender, L.C., Walsh, S. et al. (6 more authors) (2023) Female Sex but Not Oestrogen Receptor Expression Predicts Survival in Advanced Gastroesophageal Adenocarcinoma—A Post-hoc Analysis of the GO2 Trial. Cancers, 15 (9). 2591. ISSN 2072-6694

Hanna, D., Merrick, S., Ghose, A. et al. (24 more authors) (2024) Real world study of sacituzumab govitecan in metastatic triple-negative breast cancer in the United Kingdom. British Journal of Cancer, 130 (12). pp. 1916-1920. ISSN 0007-0920

Hassanieh, S., Domingo, E., Blake, A. et al. (16 more authors) (2022) 337P Prediction of poor response to oxaliplatin by an RNA signature derived and validated in colorectal cancer clinical trials. In: Annals of Oncology. ESMO Congress 2022, 09-13 Sep 2022, Paris, France. Elsevier , S691.

Royle, K-L orcid.org/0000-0003-0225-1199, Coulson, AB, Ramasamy, K et al. (26 more authors) (2022) Risk and response adapted therapy following autologous stem cell transplant in patients with newly diagnosed multiple myeloma (RADAR (UK-MRA Myeloma XV Trial): study protocol for a phase II/III randomised controlled trial. BMJ Open, 12 (11). e063037. ISSN 2044-6055

Cook, G., Ashcroft, A.J., Senior, E. et al. (17 more authors) (2024) Ixazomib as consolidation and maintenance versus observation in patients with relapsed multiple myeloma eligible for salvage autologous stem-cell transplantation (Myeloma XII [ACCoRD]): interim analysis of a multicentre, open-label, randomised, phase 3 trial. The Lancet Haematology, 11 (11). e816-e829. ISSN 2352-3026

Dawkins, B., Gkountouras, G., Meads, D. et al. (21 more authors) (2024) Cost-Effectiveness of Frailty-Adjusted Therapy in Transplant Non-Eligible Patients with Newly Diagnosed Multiple Myeloma - an Economic Evaluation of the Fitness Trial. In: Blood. The 66th ASH Annual Meeting, 07-10 Dec 2024, San Diego, USA. American Society of Hematology , pp. 385-386.

Cook, G., Pawlyn, C., Royle, K.-L. et al. (20 more authors) (2024) IMWG Frailty Score-Adjusted Therapy Delivery Reduces the Early Mortality Risk in Newly Diagnosed Tne Multiple Myeloma: Results of the UK Myeloma Research Alliance (UK-MRA) Myeloma XIV Fitness Trial. In: Blood. The 66th ASH Annual Meeting, 07 Dec 2024, San Diego, USA. American Society of Hematology , pp. 673-674.

Reed, M., Cairns, D.A. orcid.org/0000-0002-2338-0179, Pawlyn, C. et al. (13 more authors) (2023) The Impact of Epstein-Barr Virus Infection on Second Cancer Development in Newly Diagnosed Myeloma Patients Treated with Lenalidomide in the UK NCRI Myeloma XI Trial. In: Blood. 65th ASH Annual Meeting and Exposition, 09-12 Dec 2023, San Diego, USA. American Society of Hematology , pp. 3366-3368.

de Tute, R.M., Cook, G. orcid.org/0000-0001-7196-7364, Cairns, D.A. orcid.org/0000-0002-2338-0179 et al. (12 more authors) (2024) Impact of minimal residual disease (MRD) in salvage autologous stem cell transplantation for relapsed myeloma: results from the NCRI Myeloma X (intensive) trial. Bone Marrow Transplantation, 59. pp. 431-434. ISSN 0268-3369

Birch, RJ orcid.org/0000-0003-1579-1397, Peckham, D orcid.org/0000-0001-7723-1868, Wood, HM orcid.org/0000-0003-3009-5904 et al. (7 more authors) (2023) The risk of colorectal cancer in individuals with mutations of the cystic fibrosis transmembrane conductance regulator (CFTR) gene: An English population-based study. Journal of Cystic Fibrosis, 22 (3). pp. 499-504. ISSN 1569-1993

Seligmann, JF, Domingo, E, Fisher, D et al. (17 more authors) (2022) The clinical relevance of tumor RAS/TP53 dual mutation in early and metastatic colorectal cancer (CRC). In: 2022 ASCO Annual Meeting, 03-07 Jun 2022, Chicago, Il, USA and Online.

Davies, J, Muralidhar, S, Randerson-Moor, J et al. (15 more authors) (2022) Ulcerated melanoma: Systems biology evidence of inflammatory imbalance towards pro-tumourigenicity. Pigment Cell and Melanoma Research, 35 (2). pp. 252-267. ISSN 1755-1471

Bose, M, Wood, HM orcid.org/0000-0003-3009-5904, Young, C orcid.org/0000-0001-5709-4413 et al. (3 more authors) (2023) Analysis of an Indian colorectal cancer faecal microbiome collection demonstrates universal colorectal cancer-associated patterns, but closest correlation with other Indian cohorts. BMC Microbiology, 23. 52. ISSN 1471-2180

Long, E, Yin, J, Funderburk, KM et al. (20 more authors) (2022) Massively parallel reporter assays and variant scoring identified functional variants and target genes for melanoma loci and highlighted cell-type specificity. American Journal of Human Genetics, 109 (12). pp. 2210-2229. ISSN 0002-9297

Arp, D.T. orcid.org/0009-0007-7980-5539, Appelt, A.L. orcid.org/0000-0003-2792-9218, Jensen, L.H. et al. (6 more authors) (2024) Treatment planning for patients with low rectal cancer in a multicenter prospective organ preservation study. Physica Medica, 118. 103206. ISSN 1120-1797

Underwood, TSA, McNamara, AL, Appelt, A orcid.org/0000-0003-2792-9218 et al. (3 more authors) (2022) A systematic review of clinical studies on variable proton Relative Biological Effectiveness (RBE). Radiotherapy and Oncology, 175. pp. 79-92. ISSN 0167-8140

Lally, P, Miller, NE, Lawrence, C et al. (2 more authors) (2023) Associations of self-reported and device-assessed physical activity with fatigue, quality of life, and sleep quality in adults living with and beyond cancer. Journal of Sport and Health Science, 12 (6). pp. 664-673. ISSN 2095-2546

Sodergren, S., Husson, O., Rohde, G. et al. (17 more authors) (2023) Measuring What Matters To Adolescents And Young Adults With Cancer: The Importance Of Capturing Positive Experiences. In: Pediatric Blood & Cancer. 55th Congress of the International Society of Paediatric Oncology (SIOP), 11-14 Oct 2023, Ottawa, Canada. Wiley , S15-S16.

Hughes, L., Taylor, R.M. orcid.org/0000-0002-0853-0925, Beckett, A.E. orcid.org/0000-0001-5233-3390 et al. (7 more authors) (2024) The Emotional Impact of a Cancer Diagnosis: A Qualitative Study of Adolescent and Young Adult Experience. Cancers, 16 (7). 1332. ISSN 2072-6694

Williams, C. orcid.org/0000-0002-1574-653X, Seligmann, J.F. orcid.org/0000-0003-4379-6005, Guetter, C. et al. (13 more authors) (2021) Artificial intelligence-assisted immunohistochemical (IHC) evaluation of tumor amphiregulin (AREG) and epiregulin (EREG) expression as a combined predictive biomarker for panitumumab (Pan) therapy benefit in RAS wild-type (wt) metastatic colorectal cancer (mCRC): Analysis within the phase III PICCOLO trial. In: Journal of Clinical Oncology. 2021 Gastrointestinal Cancers Symposium, 15-17 Jan 2021, Online. American Society of Clinical Oncology , p. 111.

Domingo, E., Rathee, S., Blake, A. et al. (18 more authors) (2021) Abstract LB129: Stratification of radiotherapy and fluoropyrimidine-based chemotherapy from multi-omic profiling in rectal cancer biopsies. In: Cancer Research. AACR Annual Meeting 2021, 17-21 May 2021, Philadelphia, PA, USA. American Association for Cancer Research (AACR) , LB129.

Crabb, S.J., Hussain, S.A., Oughton, J.B. et al. (15 more authors) (2024) Use of gene expression patterns to identify unique molecular subtypes in muscle invasive bladder cancer: GUSTO. In: Journal of Clinical Oncology. 2024 ASCO Annual Meeting, 31 May - 04 Jun 2024, Chicago, USA. American Society of Clinical Oncology .

Williams, C, Emmerson, J, Beggs, AD et al. (12 more authors) (2022) A biomarker enrichment trial of anti-EGFR agents in right primary tumor location (rPTL), RAS wild-type (RAS-wt) advanced colorectal cancer (aCRC): ARIEL (ISRCTN11061442). In: Journal of Clinical Oncology. 2022 ASCO Annual Meeting, 03-07 Jun 2022, Online & Chicago, IL, USA. American Society of Clinical Oncology .

Booth, M.E., Wood, H.M. orcid.org/0000-0003-3009-5904, Travis, M.A. et al. (3 more authors) (2025) The relationship between the gastric cancer microbiome and clinicopathological factors: a metagenomic investigation from the 100,000 genomes project and The Cancer Genome Atlas. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. ISSN 1436-3291

Gilbert, A orcid.org/0000-0002-9142-1227, Homer, V, Brock, K et al. (18 more authors) (2022) Quality-of-life outcomes in older patients with early-stage rectal cancer receiving organ-preserving treatment with hypofractionated short-course radiotherapy followed by transanal endoscopic microsurgery (TREC): non-randomised registry of patients unsuitable for total mesorectal excision. The Lancet Healthy Longevity, 3 (12). e825-e838. ISSN 2666-7568

Yang, F, Mortlock, S, MacGregor, S et al. (5 more authors) (2021) Genetic Relationship Between Endometriosis and Melanoma. Frontiers in Reproductive Health, 3. 711123. ISSN 2673-3153

Haycock, PC, Borges, MC, Burrows, K et al. (32 more authors) (2023) The association between genetically elevated polyunsaturated fatty acids and risk of cancer. eBioMedicine, 91. 104510. ISSN 2352-3964

Thakur, R., Xu, M., Sowards, H. et al. (21 more authors) (2024) Mapping chromatin interactions at melanoma susceptibility loci and cell-type specific dataset integration uncovers distant gene targets of cis-regulation. [Preprint]

Martin, JW, Barducci, L, Scaglioni, B orcid.org/0000-0003-4891-8411 et al. (6 more authors) (2022) Robotic Autonomy for Magnetic Endoscope Biopsy. IEEE Transactions on Medical Robotics and Bionics, 4 (3). pp. 599-607. ISSN 2576-3202

Potjer, TP, van der Grinten, TWJ, Lakeman, IMM et al. (8 more authors) (2021) Association between a 46-SNP Polygenic Risk Score and melanoma risk in Dutch patients with familial melanoma. Journal of Medical Genetics, 58 (11). pp. 760-766. ISSN 0022-2593

Liyanage, UE, Law, MH, Melanoma Meta-analysis Consortium et al. (3 more authors) (2020) Is there a causal relationship between vitamin D and melanoma risk? : A Mendelian randomization study. British Journal of Dermatology, 182 (1). pp. 97-103. ISSN 0007-0963

Landewee, C.A. orcid.org/0000-0002-3177-1938, Winters, C., Martin, J. et al. (8 more authors) (2024) Magnetic flexible endoscope: a novel platform for diagnostic and therapeutic colonoscopy. iGIE, 3 (1). pp. 1-4. ISSN 2949-7086

Patterson, P, D'Agostino, NM, McDonald, FEJ et al. (8 more authors) (2021) Screening for distress and needs: Findings from a multinational validation of the Adolescent and Young Adult Psycho-Oncology Screening Tool with newly diagnosed patientsInternational AYA Cancer Distress Screening Group. Psycho-Oncology, 30 (11). pp. 1849-1858. ISSN 1057-9249

Seligmann, J., Morton, D., Seymour, M. et al. (11 more authors) (2023) 552O FOxTROT: Results of embedded phase II evaluating the addition of panitumumab (pan) to neo-adjuvant FOLFOX for patients (pts) with KRAS-wt colon cancer (CC) with extended biomarker panel. In: Annals of Oncology. ESMO Congress 2023, 2023-10-20 2023-10-24, Madrid, Spain. Elsevier , S412-S412.

Taylor, J.C. orcid.org/0000-0002-2518-5799, Burke, D., Iversen, L.H. et al. (6 more authors) (2024) Minimally Invasive Surgery for Colorectal Cancer: Benchmarking Uptake for a Regional Improvement Programme. Clinical Colorectal Cancer, 23 (4). pp. 382-391. ISSN 1533-0028

Platt, J.R., Williams, C. orcid.org/0000-0002-1574-653X, West, N. orcid.org/0000-0002-0346-6709 et al. (2 more authors) (2023) Exploring the radiological differences of lymph nodes between mismatch repair deficient and mismatch repair proficient colon cancer. In: Journal of Clinical Oncology. 2023 ASCO Annual Meeting I, 02-06 Jun 2023, Chicago, USA. American Society of Clinical Oncology .

Williams, C. orcid.org/0000-0002-1574-653X, White, M., Platt, J.R. et al. (14 more authors) (2023) The FOxTROT platform: Clinical trials and exploratory research for personalization of neoadjuvant (NA) therapy in locally advanced colon cancer (LACC)—ISRCTN83842641. In: Journal of Clinical Oncology. 2023 ASCO Annual Meeting I, 02-06 Jun 2023, Chicago, USA. American Society of Clinical Oncology .

Theophanous, S orcid.org/0000-0002-4148-3905, Lønne, P-I, Choudhury, A et al. (25 more authors) (2022) Development and validation of prognostic models for anal cancer outcomes using distributed learning: protocol for the international multi-centre atomCAT2 study. Diagnostic and Prognostic Research, 6 (1). 14. p. 14. ISSN 2397-7523

Iyizobane Ebozue, Z., Prestwich, R., Brown, S. orcid.org/0000-0002-7975-7537 et al. (7 more authors) (2023) Neurocognitive function following (chemo)radiotherapy for nasopharyngeal cancer and other head and neck cancers: A systematic review. Radiotherapy and Oncology, 188. 109863. ISSN 0167-8140

Land, J, McCourt, O, Heinrich, M et al. (6 more authors) (2020) The adapted Zelen was a feasible design to trial exercise in myeloma survivors. Journal of Clinical Epidemiology, 125. pp. 76-83. ISSN 0895-4356

Taylor, JC orcid.org/0000-0002-2518-5799, Iversen, LH, Burke, D orcid.org/0000-0002-4342-7464 et al. (5 more authors) (2022) Differences in the management of patients requiring an emergency resection for colonic cancer in two European populations. BJS Open, 6 (5). zrac126. ISSN 2474-9842

Theophanous, S., Samuel, R., Lilley, J. et al. (4 more authors) (2022) PO-1321 Prognostic factors for anal cancer treated with conformal radiotherapy – a systematic review. In: Radiotherapy and Oncology. ESTRO 2022, 06-10 May 2022, Copenhagen, Denmark/Online. Elsevier , S1115-S1116.

Birch, R.J. orcid.org/0000-0003-1579-1397, Burr, N.E., Taylor, J.C. orcid.org/0000-0002-2518-5799 et al. (5 more authors) (2025) Inequalities in colorectal cancer diagnosis by ethnic group: a population-level study in the English National Health Service. BMJ Open Gastroenterology, 12 (1). e001629. ISSN 2054-4774

Platt, JR, Todd, OM orcid.org/0000-0001-7212-8095, Hall, P et al. (14 more authors) (2023) FOxTROT2: innovative trial design to evaluate the role of neoadjuvant chemotherapy for treating locally advanced colon cancer in older adults or those with frailty. ESMO Open, 8 (1). 100642. ISSN 2059-7029

Marijnen, C., de Wilt, J., Bach, S. et al. (16 more authors) (2023) OC-0272 Organ preservation in rectal cancer: the randomised STAR-TREC phase II trial. In: Radiotherapy and Oncology. ESTRO 2023, 13/05/2023 -16/05/2023, Vienna, Austria. Elsevier .